<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766961</url>
  </required_header>
  <id_info>
    <org_study_id>TAE</org_study_id>
    <nct_id>NCT00766961</nct_id>
  </id_info>
  <brief_title>TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy</brief_title>
  <official_title>Randomized Comparison of Trans-catheter Arterial Embolization (TAE) and Surgery in Patients With Major Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King Chulalongkorn Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the outcomes of trans-catheter arterial embolization (TAE)
      and surgery as salvage therapy of peptic ulcer bleeding after failed endoscopic therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to examine the hypothesis that trans-catheter arterial embolization
      (TAE) is safer than and probably as effective as surgery in the control of bleeding from
      ulcers after failed endoscopic therapy. Patients with major arterial bleeding that cannot be
      stopped by endoscopic therapy will be randomly assigned to receive immediate TAE or surgery.
      Primary outcome will be death within 30 days of randomization. Secondary outcomes include
      recurrent bleeding after assigned treatment, need for additional intervention either in the
      form of interventional radiology or surgery, and post procedural morbidities.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality within 30 days of randomization</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrent bleeding after assigned treatment</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The need for additional intervention either in the form of interventional radiology</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post procedural morbidities</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The need for additional intervention either in the form of surgery</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Peptic Ulcer</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>TAE group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Trans-catheter arterial embolization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trans-catheter arterial embolization</intervention_name>
    <description>Trans-catheter arterial embolization</description>
    <arm_group_label>TAE group</arm_group_label>
    <other_name>TAE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Surgery</description>
    <arm_group_label>Surgery group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with bleeding peptic ulcers documented during endoscopic therapy AND anyone
             of the following:

          -  Forrest I bleeding that fails to be controlled by therapy during first endoscopy

          -  Check endoscopy after clinical re-bleeding of Forrest I bleeding

          -  Forrest IIa or an initial IIb but a sizable artery unveiled upon clot elevation in a
             high risk ulcer defined by:

          -  posterior bulbar duodenal ulcer &gt; 2cm, or

          -  an angular notch / lesser curve gastric ulcer &gt; 5cm that fail an attempt at endoscopic
             therapy together with evidence of a significant bleed (hypotension with SBP &lt; 90mmHg,
             fresh hematemesis or hematochezia).

        Exclusion Criteria:

          -  Refusal to participate in trial

          -  No consent

          -  Age &lt; 18

          -  Pregnancy

          -  Moribund patients

          -  Patients with terminal malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James YW LAU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endoscopy Center, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2008</study_first_submitted>
  <study_first_submitted_qc>October 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2008</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>James Yun-wong Lau</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Peptic ulcer bleeding uncontrolled by endoscopic therapy.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

